Literature DB >> 15827761

Agreement of expert judgment in causality assessment of adverse drug reactions.

Yannick Arimone1, Bernard Bégaud, Ghada Miremont-Salamé, Annie Fourrier-Réglat, Nicholas Moore, Mathieu Molimard, Françoise Haramburu.   

Abstract

BACKGROUND: Global introspection is, with operational algorithms and Bayes' theorem, one of the three main approaches used to assess the causal relationship between a drug treatment and the occurrence of an adverse event.
OBJECTIVE: To analyze and compare the judgments of five senior experts using global introspection about drug causation on a random set of putative adverse drug reactions.
METHODS: A random sample of 150 drug-effect pairs was constituted. For each pair, five senior experts had to independently assess the probability of drug causation from 0 to 1 by using a 100 mm visual analog scale (VAS). For analysis, those probabilities were secondarily split into seven levels of causality: excluded (0-0.05); unlikely (0.06-0.25); doubtful (0.26-0.45); unassessable/unclassifiable (0.46-0.55); plausible (0.56-0.75); likely (0.75-0.95); and certain (0.95-1). Agreement among the five experts was assessed using kappa coefficients (kappa).
RESULTS: The overall agreement between experts was poor (kappa=0.20), although significantly different from chance, and varied according to the level of causality. It was lower for the unlikely, doubtful, unassessable/unclassifiable, and plausible categories (kappa=0.03, 0.03, -0.01, and 0.13, respectively) than for VAS extremes: excluded, likely, and certain (kappa=0.40, 0.32, and 0.30, respectively).
CONCLUSION: This study confirms that experts express marked disagreements when assessing drug causality independently. The agreement rate was lower for intermediate levels of causality, especially when strong evidence was lacking for confirming or ruling out drug causality. Therefore, in a decision-making context, a step-by-step consensual approach such as the Delphi method seems necessary to make the assessment of such cases more reliable.

Entities:  

Mesh:

Year:  2005        PMID: 15827761     DOI: 10.1007/s00228-004-0869-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

Review 1.  Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability.

Authors:  A F Macedo; F B Marques; C F Ribeiro; F Teixeira
Journal:  J Clin Pharm Ther       Date:  2003-04       Impact factor: 2.512

2.  Delphi as a method to establish consensus for diagnostic criteria.

Authors:  Brent Graham; Glenn Regehr; James G Wright
Journal:  J Clin Epidemiol       Date:  2003-12       Impact factor: 6.437

3.  Clinical biostatistics. XXX. Biostatistical problems in 'compliance bias'.

Authors:  A R Feinstein
Journal:  Clin Pharmacol Ther       Date:  1974-11       Impact factor: 6.875

4.  The ambiguity of adverse drug reactions.

Authors:  J Koch-Weser; E M Sellers; R Zacest
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

5.  Reasons for disagreement in the standardized assessment of suspected adverse drug reactions.

Authors:  T A Hutchinson; K M Flegel; H HoPingKong; W S Bloom; M S Kramer; E G Trummer
Journal:  Clin Pharmacol Ther       Date:  1983-10       Impact factor: 6.875

6.  Adverse drug reactions: physicians' opinions versus a causality assessment method.

Authors:  G Miremont; F Haramburu; B Bégaud; J C Péré; J Dangoumau
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  [Sensitivity and specificity of imputability criteria. Study and comparison of these efficacity indices for 7 methods].

Authors:  J C Péré; M H Godin; B Bégaud; F Haramburu; H Albin
Journal:  Therapie       Date:  1985 Sep-Oct       Impact factor: 2.070

8.  [Bayesian approach to the imputability of undesirable phenomena to drugs].

Authors:  M Auriche
Journal:  Therapie       Date:  1985 Sep-Oct       Impact factor: 2.070

9.  Standardized assessment of drug-adverse reaction associations--rationale and experience.

Authors:  J Venulet; A Ciucci; G C Berneker
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-09

10.  An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians.

Authors:  J M Leventhal; T A Hutchinson; M S Kramer; A R Feinstein
Journal:  JAMA       Date:  1979-11-02       Impact factor: 56.272

View more
  36 in total

1.  Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.

Authors:  Sandra L Kane-Gill; Elizabeth A Forsberg; Margaret M Verrico; Steven M Handler
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

Review 2.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

3.  Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.

Authors:  Yannick Arimone; Ghada Miremont-Salamé; Françoise Haramburu; Mathieu Molimard; Nicholas Moore; Annie Fourrier-Réglat; Bernard Bégaud
Journal:  Br J Clin Pharmacol       Date:  2007-08-15       Impact factor: 4.335

4.  A new approach to identify, classify and count drug-related events.

Authors:  Thomas Bürkle; Fabian Müller; Andrius Patapovas; Anja Sonst; Barbara Pfistermeister; Bettina Plank-Kiegele; Harald Dormann; Renke Maas
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

5.  Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.

Authors:  Harshad Devarbhavi; Guruprasad Aithal; Sombat Treeprasertsuk; Hajime Takikawa; Yimin Mao; Saggere M Shasthry; Saeed Hamid; Soek Siam Tan; Cyriac Abby Philips; Jacob George; Wasim Jafri; Shiv K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

Review 6.  Does orlistat cause acute kidney injury?

Authors:  Michael M Beyea; Amit X Garg; Matthew A Weir
Journal:  Ther Adv Drug Saf       Date:  2012-04

7.  Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT).

Authors:  Sinem Ezgi Gulmez; Dominique Larrey; Georges-Philippe Pageaux; Séverine Lignot-Maleyran; Corinne de Vries; Miriam Sturkenboom; Susana Perez-Gutthann; Jacques Bénichou; Franco Bissoli; Yves Horsmans; Jacques Bernuau; Bruno Stricker; Douglas Thorburn; Patrick Blin; Nicholas Moore
Journal:  Eur J Clin Pharmacol       Date:  2012-08-10       Impact factor: 2.953

8.  Is Duhuo Jisheng Tang containing Xixin safe? A four-week safety study.

Authors:  Shu-Ching Hsieh; Jung-Nien Lai; Pau-Chung Chen; Chao-Chung Chen; Huey-Jen Chen; Jung-Der Wang
Journal:  Chin Med       Date:  2010-02-11       Impact factor: 5.455

9.  Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study.

Authors:  Lukas Schwake; Ines Wollenschläger; Wolfgang Stremmel; Jens Encke
Journal:  Intensive Care Med       Date:  2008-08-12       Impact factor: 17.440

Review 10.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.